Skip to content

Application of Anaesthesia Management under Monitoring in Respiratory Endoscopy of Pulmonary Tuberculosis Patients

Application of Anaesthesia Management under Monitoring in Respiratory Endoscopy of Pulmonary Tuberculosis Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038195
Enrollment
Unknown
Registered
2020-09-13
Start date
2020-09-15
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tuberculosis

Interventions

C group:Midazolam 0.05mg/kg before tracheoscopy, propofol 0.5 mg/kg. after tracheoscopy entered glottis
R group:Medazolam 0.05 mg/kg, remifentanil 0.1 ug/kg, propofol 0.5 mg/kg. after tracheoscopy after lidocaine local anesthesia
D group:The lidocaine was injected intravenously for 10 minutes into dexmedetomidine 0.5 ug/kg, then continuously pumped 1 ug/kg/h. Medazolam 0.05 mg/kg, remifentanil 0.1 before tracheoscopy mg/kg.0.5

Sponsors

The Fourth People's Hospital of Huai'an City, Jiangsu Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Between 18 and 70 years of age, men and women are not limited, unintentional, liver, kidney and other important organ diseases, asa grade i~ii patients. 2) The diagnosis of pulmonary tuberculosis should be in accordance with the clinical diagnosis of pulmonary tuberculosis and the diagnosis of patients to be examined by tracheoscopy, or suspected pulmonary tuberculosis patients, respiratory endoscopy to find bacteriological, molecular biology, histological evidence of patients. 3) Willing and able to participate in the study, willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients with mental illness or those who can not cooperate; 2) Patients with other serious diseases and severe lung damage; 3) Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Tracheoscopy score;Ramsay;

Countries

China

Contacts

Public ContactGuangxing Geng

The Fourth People's Hospital of Huai' an City, Jiangsu Province

744062762@qq.com+86 13655156540

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026